Skip to main content

Table 5 Annual growth rates

From: Impact of orphan drugs on Latvian budget

Expenditure

2010–2011

2011–2012

2012–2013

2013–2014

Orphan drugs (all)

23.52 %

20.16 %

−30.01 %

23.16 %

Orphan drugs (excl. Glivec)

47.73 %

70.67 %

23.00 %

23.16 %

Total pharmaceutical market

4.88 %

1.82 %

4.10 %

2.75 %

Total drug reimbursement budget

11.61 %

−1.01 %

0.32 %

4.21 %